Fludarabine, Cytarabine, and Idarubicin with or without Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia

This retrospective cohort study compares safety and efficacy of fludarabine, cytarabine, and idarubicin without or with venetoclax in patients with relapsed and refractory acute myeloid leukemia patients.